Intervention not reported
Co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic gastrostomy) · surgical patients
It is very uncertain whether the intervention changes co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic… (very low certainty).
1 finding from 1 review
Intervention not reported
One dose of cefotiam or cefmetazol versus four doses of cefotiam or cefmetazol (elective surgery for colon cancer) · surgical patients
It is very uncertain whether the intervention changes one dose of cefotiam or cefmetazol versus four doses of cefotiam or… (very low certainty).
1 finding from 1 review
Intervention not reported
Pefloxacin versus cefazolin and oxacillin (tibial fracture requiring external fixation) · surgical patients
It is very uncertain whether the intervention changes pefloxacin versus cefazolin and oxacillin (tibial fracture requiring… (very low certainty).
1 finding from 1 review
Intervention not reported
Vancomycin and cefazolin versus cefazolin (open fractures) · surgical patients
It is very uncertain whether the intervention changes vancomycin and cefazolin versus cefazolin (open fractures) (very low certainty).
1 finding from 1 review
Intervention not reported
Vancomycin and cefazolin versus cefazolin (vascular surgery) · surgical patients
It is very uncertain whether the intervention changes vancomycin and cefazolin versus cefazolin (vascular surgery) (very low certainty).
1 finding from 1 review
Intervention not reported
Vancomycin and cefazolin versus daptomycin and cefazolin (vascular surgery) · surgical patients
It is very uncertain whether the intervention changes vancomycin and cefazolin versus daptomycin and cefazolin (vascular… (very low certainty).
1 finding from 1 review
Intervention not reported
Vancomycin versus teicoplanin (paediatric cardiac surgery) · surgical patients
1 finding from 1 review
Intervention not reported
Vancomycin versus cefuroxime (coronary artery bypass graft without valvular disease) · surgical patients
It is very uncertain whether the intervention changes vancomycin versus cefuroxime (coronary artery bypass graft without… (very low certainty).
1 finding from 1 review
Intervention not reported
One dose of cefotiam or cefmetazol versus four doses of cefotiam or cefmetazol (elective surgery for colon cancer) · surgical patients
It is very uncertain whether the intervention changes one dose of cefotiam or cefmetazol versus four doses of cefotiam or… (very low certainty).
1 finding from 1 review
Intervention not reported
Kanamycin, erythromycin and cefotiam versus cefotiam (surgery for colorectal diseases) · surgical patients
It is very uncertain whether the intervention changes kanamycin, erythromycin and cefotiam versus cefotiam (surgery for… (very low certainty).
1 finding from 1 review
Intervention not reported
Vancomycin versus cefuroxime (coronary artery bypass graft without valvular disease) · surgical patients
It is very uncertain whether the intervention changes vancomycin versus cefuroxime (coronary artery bypass graft without… (very low certainty).
1 finding from 1 review
Intervention not reported
Cefamendole versus cefamendole and gentamycin (median sternotomy) · surgical patients
It is very uncertain whether the intervention changes cefamendole versus cefamendole and gentamycin (median sternotomy) (very low certainty).
1 finding from 1 review
Intervention not reported
Cefazolin versus cefamendole (median sternotomy) · surgical patients
It is very uncertain whether the intervention changes cefazolin versus cefamendole (median sternotomy) (very low certainty).
1 finding from 1 review
Intervention not reported
Cefazolin versus cefazolin and gentamycin (median sternotomy) · surgical patients
It is very uncertain whether the intervention changes cefazolin versus cefazolin and gentamycin (median sternotomy) (very low certainty).
1 finding from 1 review
Intervention not reported
Co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic gastrostomy) · surgical patients
The intervention may leads to lower co‐amoxiclav or cefotaxime versus placebo (percutaneous endoscopic… (low certainty).
1 finding from 1 review
Intervention not reported
Daptomycin and cefazolin versus cefazolin (vascular surgery) · surgical patients
It is very uncertain whether the intervention changes daptomycin and cefazolin versus cefazolin (vascular surgery) (very low certainty).
1 finding from 1 review
Intervention not reported
Daptomycin versus vancomycin or semisynthetic penicillin · patients with MRSA‐infected non surgical wounds
It is very uncertain whether the intervention changes daptomycin versus vancomycin or semisynthetic penicillin (very low certainty).
1 finding from 1 review
Intervention not reported
Ertapenem versus piperacillin/tazobactam · patients with MRSA‐infected non surgical wounds
It is very uncertain whether the intervention changes ertapenem versus piperacillin/tazobactam (very low certainty).
1 finding from 1 review
Intervention not reported
Moxifloxacin versus piperacillin/tazobactam followed by amoxycillin/clavulanate · patients with MRSA‐infected non surgical wounds
It is very uncertain whether the intervention changes moxifloxacin versus piperacillin/tazobactam followed by… (very low certainty).
1 finding from 1 review
All cause‐mortality · cancer patients with afebrile neutropenia following chemotherapy
Summary of findings: quinolone prophylaxis probably leads to higher all cause‐mortality compared with TMP‐SMZ prophylaxis (moderate certainty).
1 finding from 1 review